Airdrie

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This trial is looking at bone marrow samples to help work out the best treatment for myeloma.

This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.

This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.

This trial is looking at giving acalabrutinib with chemotherapy for Diffuse Large B Cell Lymphoma (DLBCL).

This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.

This study is open to people who are newly diagnosed with B cell or T cell acute lymphoblastic leukaemia (ALL) and haven’t started treatment.

This study is for families who do not have a gene change (mutation) known to increase bowel cancer risk or a family history of bowel cancer.

This is the first sentence of the introduction only, copied from the summary below. There should not be any links and it must be no longer than 160 characters

This trial is looking at treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL).